The Billionaire’s Bold Trip: Bryan Johnson and the Public Psychedelic Experiment
In a move that has ignited both curiosity and criticism, longevity entrepreneur Bryan Johnson, famously known for his "Don’t Die" mantra and relentless pursuit of eternal youth, recently invited the world to witness his most unconventional experiment yet: a five-and-a-half-hour livestream of him consuming a high dose of psychedelic mushrooms. The event, held at a licensed psilocybin center in Oregon, where the substance has been legal for therapeutic use since 2023, aimed to explore the potential of psilocybin in enhancing nearly 250 wellness biomarkers, ranging from brain connectivity to cortisol and testosterone levels.
"Come watch me trip balls," Johnson, 48, declared on X (formerly Twitter) ahead of the livestream, a statement that perfectly encapsulates the audacious, and some might say, performative nature of his latest endeavor. This isn’t just about personal exploration; Johnson envisions psychedelics playing a significant role in our lives, potentially even as a longevity therapy. "There’s a potential for psychedelics to play a more important role in all of our lives, and wouldn’t it be amazing if it was also a longevity therapy," he proclaimed during the broadcast.
The Pre-Trip Ritual: High-Tech and High Stakes
Before embarking on his psychedelic journey, Johnson engaged in a series of scientific-sounding preparations. He donned a $50,000 neuroimaging helmet from Kernel, a company he founded, to measure his brain activity. Saliva samples and temperature readings were also collected, adding to the elaborate scientific theater. The stakes, for Johnson at least, seemed high. Following a previous, un-livestreamed mushroom trip in November, Johnson reported a remarkable resurgence in spontaneous erections, a phenomenon he hadn’t experienced since childhood, which he attributed to a potentially more "flexible, youthful nervous system."
Then came the main event: a potent concoction of over five grams of powdered mushrooms mixed with lemon juice. Johnson’s grimace as he consumed the mixture marked the dawn of a peculiar new era – one of live celebrity psychedelic exhibitionism. This, many observers argue, stands in stark contrast to the deeply introspective nature typically associated with psychedelic experiences.
A Digital Circus or a Catalyst for Change?
The livestream itself, which has garnered over 1.1 million views, was a curious blend of the profound and the peculiar. It featured Johnson’s 20-year-old son, Talmage, who has previously participated in Johnson’s controversial blood-infusion experiments aimed at rejuvenation. Journalist Ashlee Vance and Salesforce CEO Mark Benioff were also present, as was a DJ set from the artist Grimes. Notably, YouTuber MrBeast, advertised on a playful poster for the event, was absent, a fact that might have been seen as a blessing by those who were, shall we say, on a different wavelength.
Critics were quick to point out the potential drawbacks of livestreaming such an intense experience. The pressure of a global audience, they argue, could lead to fragmented attention and performance anxiety, potentially hindering the very introspective process that psychedelics are often sought for. Johnson himself seemed to acknowledge this risk, voicing his concern before the ceremony: "I guess the biggest question is, can I not go off the rails?"
Rayyan Zafar, a postdoctoral fellow at the Centre for Psychedelic Research and Neuropsychopharmacology at Imperial College London, voiced her reservations: "Bryan’s setup speaks more to ego enrichment than ego dissolution and is characteristic of many of his pseudoscientific pursuits. These sorts of experiences are often best held with an introspective and internal focus." She highlighted that the focus on external performance might be antithetical to the "ego death" – a profound dissolution of the sense of self – that many seek in psychedelic journeys.
Jamie Wheal, author of "Recapture the Rapture," was even more direct, labeling the project a "circus of self-indulgence" and an act of "digital narcissism." He questioned whether this was the psychedelic renaissance that advocates had envisioned. When asked for a response to these critiques, Johnson offered a polite but dismissive, "Whoever said this, I wish them well."
Demystifying or Demonstrating?
Despite the criticisms, Johnson’s highly public display could, paradoxically, serve a beneficial purpose: reducing the stigma surrounding psychedelic use. Hamilton Morris, a journalist and consultant in the psychedelics industry, known for his own on-camera drug explorations in the show "Hamilton’s Pharmacopoeia," commented during the livestream: "I think it’s fine and good to show people what the experience [of taking psychedelics] looks like, to demystify it to some extent, to show that it can be beneficial." The sheer visibility of the event, even if controversial in its execution, has undeniably brought psychedelics into mainstream conversation.
The Intersection of Psychedelics, Longevity, and Politics
Johnson’s experiment arrives at a pivotal moment for psychedelics. Researchers are increasingly building a strong scientific case for their efficacy in treating various mental health conditions. However, concerns are mounting about the growing influence of right-wing figures within the field. The presence of Salesforce CEO Mark Benioff, a self-proclaimed "avid" Donald Trump supporter, alongside David Friedberg, co-host of the "All-In" podcast and a figure closely associated with the Trump administration, on the stream, highlighted this complex intersection.
Friedberg chimed in with a scientific claim: "There have been studies that have shown that some of these compounds in these psychedelic substances actually change the gene expression profile and as a result can have rejuvenating effects. This is real science." This statement, while presented as fact, underscores the fine line between emerging scientific understanding and speculative claims, particularly when amplified by influential personalities.
Benioff’s seemingly off-the-cuff remark about a "sponsorship of a sleep mask" while Johnson was still in his altered state hinted at another, perhaps less altruistic, potential outcome: commercialization. The natural byproduct of such high-profile attention is increased exposure for Johnson’s own ventures, including his supplement range, Blueprint. Indeed, ads for his "longevity mix" began appearing on social media shortly after the livestream.
The Missing Voices: Science vs. Spectacle
A notable absence from the livestream was that of credentialed scientists actively involved in psychedelic research. Colette Schmitt, founder of Decriminalize Nature Philadelphia, an advocacy group for psychedelic decriminalization, expressed concern: "Science isn’t declaring something as ‘truth’ on X, or packaging speculation as ‘suppressed longevity science’ while funneling people toward unregulated products [namely, Johnson’s supplement range]." She emphasized the urgent need for factual science, especially within the psychedelic movement, which she sees as vulnerable to "high suggestibility meets low scientific literacy."
This sentiment resonates with the broader challenge of navigating the burgeoning psychedelic landscape. While the potential therapeutic benefits are exciting, the rush to capitalize on the trend, often without rigorous scientific backing, poses significant risks.
The Aftermath and the Future
As the psychedelic journey subsided, the livestream continued with Grimes’s eclectic DJ set and a conversation between Johnson, his father Richard, and his son Talmage. Johnson described the experience as "a journey. It was a force that demanded respect. It was challenging." One can only imagine how much more challenging it would have been without the watchful eyes of millions.
Ultimately, the long-term health benefits for Johnson, who amassed his fortune from the sale of Braintree for $800 million in 2013, remain to be seen. Whether this public display will truly advance the cause of psychedelic science or simply serve as another chapter in his ongoing quest to conquer mortality is a question that only time, and perhaps more rigorous, less performative studies, can answer. The event highlights a critical juncture for psychedelics: a moment where the potential for groundbreaking discovery meets the powerful allure of spectacle and commerce. The world is watching, and the implications for how we understand and integrate these powerful substances are profound.